Tervisetehnoloogiate Arenduskeskus AS (The Competence Centre on Health Technologies, CCHT) is a biotechnology company focused on research and product development in personal medicine, drug development and both human and veterinary reproductive medicine. We collaborate closely with leading Estonian scientists, universities and biotechnology companies as well as scientific, medical and R&D institutions from Europe, Asia and America.
PGS - Preimplantation genetic screening
Preimplantation genetic screening is a genetic analysis that evaluates embryo chromosome number prior to transfer in an IVF cycle.
NIPT - Non-invasive prenatal testing
Non-invasive prenatal testing is the newest and the most sensitive screening method for identifying fetal genetic diseases already in the first month of pregnancy.
New evidence-based personalised medicine tool FERTIFY® for predicting female fertility and age-related infertility risk.
Dr. Velthut-Meikas talked at ESHRE 2018 Barcelona
Recent findings of a comprehensive two centre RNA-seq study were…Read more ❯❯
CCHT’s new genomic pipeline for NIPT
Recent publication of Scientific Reports introduced CCHT’s new genomic pipeline…Read more ❯❯
Postimees: Triin Laisk, a researcher at Tervisetehnoloogiate Arenduskeskus AS has focused on increasing the awareness on female fertility
28.03.2017 Postimees: Triin Laisk, a researcher at Tervisetehnoloogiate Arenduskeskus AS…Read more ❯❯